Parkinson's Disease

Researchers have uncovered another piece of the Parkinson’s disease puzzle, identifying that particular immune cells are active long before the hallmark motor symptoms become apparent. It paves the way for the development of earlier diagnostic tools.

Catching the onset of Parkinson's Disease early can be critical to slowing the disease's progression and improving a patient's life. A new test that uses nothing more than a sample of someone's ear wax is set to do exactly that.

A protein found in our cells has emerged as a secret weapon against biological aging, acting like a glue to repair damaged DNA and ward off neurological degeneration including that seen in motor neuron, Alzheimer’s and Parkinson’s diseases.

Neighborhoods near golf courses are often considered desirable locations. However, a new study suggests that houses within a few miles of manicured fairways and greens may not be such hot property for your health and wellbeing.

In a new study, researchers have identified a way to stop cells from dying, opening the door to developing treatments that slow the progression of neurodegenerative conditions like Parkinson’s disease.

For some common medical conditions, timing is everything when it comes to taking medications. Now, a customizable capsule engineered at UC San Diego could simplify complicated dosing schedules thanks to a unique staged release system.

Researchers have developed a simple, non-invasive method of diagnosing Parkinson’s disease early using an eye scan. It could mean treatment can start sooner or, alternatively, could be used to monitor the disease’s progression.

Researchers have developed nerve grafts, currently being trialed as a treatment for Parkinson’s disease, that are invisible to the body’s immune system. It could mean that giving risky post-transplant anti-rejection drugs is soon a thing of the past.

A mainstay of Parkinson's disease treatment, levodopa can cause nasty side-effects with long-term use. A recent human trial found that a new drug significantly reduces these effects, representing a breakthrough milestone in Parkinson’s treatment.

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to switch it back on have remained elusive – until now.

Americans will soon have access to an infusion treatment that provides round-the-clock relief of Parkinson's symptoms. The US FDA has green-lit this innovative drug delivery system, which is expected to be available in the fourth quarter of 2025.

The Michael J. Fox Foundation for Parkinson's Research has partnered with global healthcare company Grifols to identify biomarkers of Parkinson’s disease well in advance of symptoms appearing. The initiative could lead to new diagnostic tools and treatments.